A Randomized Phase II Trial of Multi-epitope Vaccination with Melanoma Peptides for Cytotoxic T-Cells and Helper T-Cells for Patients with Metastatic Melanoma (E1602)

PURPOSE: This multicenter randomized trial was designed to evaluate whether melanoma helper peptides augment cytotoxic T-lymphocyte (CTL) responses to a melanoma vaccine and improve clinical outcome in patients with advanced melanoma. PATIENTS AND METHODS: One hundred seventy-five patients with meas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Slingluff, Craig L., Lee, Sandra, Zhao, Fengmin, Chianese-Bullock, Kimberly A., Olson, Walter, Butterfield, Lisa H., Whiteside, Theresa, Leming, Philip D., Kirkwood, John M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3813832/
https://ncbi.nlm.nih.gov/pubmed/23653149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados